Filing Details
- Accession Number:
- 0001437749-24-003016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-02-02 19:07:36
- Reporting Period:
- 2024-01-31
- Accepted Time:
- 2024-02-02 19:07:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668243 | Urogen Pharma Ltd. | URGN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1763581 | Mark Schoenberg | 400 Alexander Park Drive Princeton NJ 08540 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2024-01-31 | 2,000 | $0.00 | 150,560 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-01-31 | 1,137 | $15.74 | 149,423 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2024-01-31 | 1,333 | $0.00 | 150,756 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-01-31 | 758 | $15.74 | 149,998 | No | 4 | S | Direct | |
| Ordinary Shares | Acquisiton | 2024-01-31 | 3,333 | $0.00 | 153,331 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2024-01-31 | 1,894 | $15.74 | 151,437 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Restricted Stock Units | Disposition | 2024-01-31 | 2,000 | $0.00 | 2,000 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2024-01-31 | 1,333 | $0.00 | 1,333 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Disposition | 2024-01-31 | 3,333 | $0.00 | 3,333 | $0.00 |
| Ordinary Shares | Restricted Stock Units | Acquisiton | 2024-01-31 | 10,000 | $0.00 | 10,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | M | Direct | ||
| 1,334 | No | 4 | M | Direct | ||
| 6,667 | No | 4 | M | Direct | ||
| 10,000 | No | 4 | A | Direct |
Footnotes
- Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer.
- Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.
- The reporting person was granted RSUs on January 31, 2021 representing 6,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2022.
- The reporting person was granted RSUs on January 31, 2022 representing 4,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2023.
- The reporting person was granted RSUs on January 31, 2023 representing 10,000 ordinary shares. The RSUs will vest in three equal annual installments from January 31, 2024.
- 1/3 of the shares underlying the restricted stock units will vest on each of January 31, 2025, January 31, 2026 and January 31, 2027.
Billionaire Hedge Funds
